Financière de Tubize SA (EBR:TUB)

Market Cap	10.51B +86.3%
Revenue (ttm)	n/a
Net Income	93.23M +3.5%
EPS	2.09 +3.5%
Shares Out	44.51M
PE Ratio	112.78
Forward PE	n/a
Dividend	1.08 (0.47%)
Ex-Dividend Date	May 7, 2026

Volume	13,820
Open	230.80
Previous Close	230.80
Day's Range	230.20 - 236.20
52-Week Range	123.20 - 250.50
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 21, 2026

About Financière de Tubize

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1928
• Employees: 3
• Stock Exchange: Euronext Brussels
• Ticker Symbol: TUB